Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Mutations in DKGE cause C3 glomerulopathy

Nov. 12, 2018

Purinergic receptor mutations cause congenital neurogenic bladder

Nov. 12, 2018

Visterra initiates first-in-human study with VIS-649 for IgA nephropathy

Nov. 8, 2018

IP6 analogues explored as treatment for kidney stones

Nov. 8, 2018

INS-3001 demonstrates efficacy in rat model of vascular calcifications

Nov. 7, 2018

Goldfinch Bio compound targets TRPC5 for the treatment of focal segmental glomerulosclerosis

Nov. 6, 2018

Acute kidney injury prevented in mice by prophylactic treatment with DNase I inhibitor

Nov. 5, 2018

ZMYM2 -- a new candidate gene for congenital anomalies of the kidney and urinary tract

Nov. 5, 2018

New compound GDT-01 improves diabetic nephropathy in ZSF1 rats

Oct. 31, 2018

LY-3358966 potently inhibits intestinal phosphate absorption in animal models

Oct. 31, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...